Holen Sie sich die Stockscreener-App
3.42
0.29%
0.010
Handel nachbörslich:
3.42
Schlusskurs vom Vortag:
$3.41
Offen:
$3.1797
24-Stunden-Volumen:
122.22K
Relative Volume:
1.43
Marktkapitalisierung:
$29.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.4678
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
+12.50%
1M Leistung:
-15.97%
6M Leistung:
-16.79%
1J Leistung:
+44.30%
1-Tages-Spanne:
$3.1713
$3.48
1-Wochen-Bereich:
$2.86
$3.525
52-Wochen-Spanne:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
433 PLAZA REAL, BOCA RATON
Vergleichen Sie LIXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.42 | 29.68M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Retail Trends: Is Lixte Biotechnology Holdings Inc a stock for growth or value investors2025 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - NewMediaWire
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - Digital Journal
Datavault AI (NASDAQ: DVLT) Closes Acquisition of API Media Innovation - financial-news.co.uk
De La Soul Set to Lead Good Health Summit at Morehouse College - EBONY Magazine
Stop Loss: Can C3is Inc weather a recessionEarnings Overview Summary & Safe Capital Growth Plans - baoquankhu1.vn
LIXTE Biotechnology Advances Novel Cancer Therapy Approach Targeting PP2A Enzyme - citybuzz -
Spartan Capital Securities, LLC Proudly Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering - Big News Network.com
Highs Report: What makes Lixte Biotechnology Holdings Inc Equity Warrant stock attractive today2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Is Lixte Biotechnology Holdings Inc stock a value trapFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
LIXTE Biotechnology Holdings (LIXT) Sponsors Good Health Mind, Body and Soul Summit - Yahoo Finance
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - Digital Journal
LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College, Linking Cancer Research to Community Wellness - citybuzz -
De La Soul's 'Good Health' summit targets Black men's wellness - Stock Titan
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - The Globe and Mail
Lixte Biotechnology to Present at DealFlow Discovery Conference as Clinical Trials Advance - citybuzz -
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - manilatimes.net
How Lixte Biotechnology Holdings Inc. stock compares to growth peersSector Performance Review & Rapid Portfolio Trading - bollywoodhelpline.com
Is Lixte Biotechnology Holdings Inc. a stock for growth or value investorsQuarterly Earnings Summary & Real-Time Volume Trigger Notifications - bollywoodhelpline.com
Breakout Move: Can Arvinas Inc grow without external fundingJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
Aug Movers: Is OPAD a play on infrastructure spending2025 Trade Ideas & Expert Approved Trade Ideas - baoquankhu1.vn
Pullback Watch: Whats the profit margin of Lixte Biotechnology Holdings IncJuly 2025 Action & Growth Oriented Trading Recommendations - baoquankhu1.vn
Institution Moves: How Lixte Biotechnology Holdings Inc stock performs after earningsJuly 2025 Market Mood & Low Volatility Stock Suggestions - Bộ Nội Vụ
LIXTE Biotechnology Engages IBN to Amplify Communications for Cancer Therapy Development - citybuzz -
About Us - FinancialContent
LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy - GuruFocus
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. - The Manila Times
Breakout Zone: Can Lixte Biotechnology Holdings Inc Equity Warrant withstand a market correctionPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Weekly Trades: How Lixte Biotechnology Holdings Inc stock compares to growth peersEarnings Performance Report & Real-Time Buy Signal Notifications - Bộ Nội Vụ
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationTreasury Yields & Expert-Curated Trade Recommendations - ulpravda.ru
Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit & Smart Swing Trading Techniques - Улправда
Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesPortfolio Return Summary & Entry and Exit Point Strategies - ulpravda.ru
Should I hold or sell Lixte Biotechnology Holdings Inc. stock in 2025Weekly Investment Summary & Accurate Technical Buy Alerts - Улправда
Can Lixte Biotechnology Holdings Inc. (8640) stock ride next bull market cycleQuarterly Market Review & Technical Buy Zone Confirmation - Улправда
LIXTE Biotechnology Holdings (LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - NewMediaWire
Will Lixte Biotechnology Holdings Inc. (8640) stock beat revenue estimatesFed Meeting & Low Risk Entry Point Tips - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Lixte Biotechnology Expands Ovarian Cancer Trial with MD Anderson and GSK - citybuzz -
Will Lixte Biotechnology Holdings Inc. stock benefit from infrastructure spending2025 Volume Leaders & AI Driven Stock Reports - ulpravda.ru
Lixte Biotechnology files to sell 5.26M shares of common stock, warrants - MSN
How strong is Lixte Biotechnology Holdings Inc. Equity Warrant stock revenue growth2025 Trade Ideas & Entry Point Strategy Guides - Улправда
Lixte Biotechnology announces new registered direct offering - MSN
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - financial-news.co.uk
Breakout Zone: Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Weekly Recap & Real-Time Market Sentiment Reports - Улправда
Can Lixte Biotechnology Holdings Inc. stock continue upward trendEarnings Forecast Updates & High Yield Trading Growth - ulpravda.ru
Lixte Biotechnology Holdings (NASDAQ: LIXT) Announces $4.3M Registered Direct Offering Priced at Market - Digital Journal
LIXTE Biotechnology Advances Novel Cancer Treatment Platform Through Clinical Trials and Strategic Moves - citybuzz -
Lixte Biotechnology Holdings Secures $4.3 Million in Registered Direct Offering to Advance Cancer Drug Development - citybuzz -
About Us | Oil & Gas JournalLIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’ - FinancialContent
Pasadena Star News - FinancialContent
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):